OBJECTIVE
We evaluated the difference in and significance of cancer cell metabolism by molecular subtyping of triple-negative breast carcinoma.
METHODS
Tissue microarrays from 122 surgical specimens of triple-negative breast carcinoma patients and immunohistochemical staining for CK5/6, epidermal